Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-31

Clinical Trial Update: Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME [NA]

View source ↗

Summary

A completed clinical study evaluated the Everads Injector for suprachoroidal administration of triamcinolone acetonide suspension in diabetic macular edema. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everads Injector
  • Triamcinolone Acetonide Suspension (Triamcinolone Acetonide)

Snippet

Sponsor: Everads Therapy | Conditions: Diabetic Macular Edema | NA | Status: COMPLETED